TheraVet  is a biotech start-up company, created in November 2017 which develops innovative treatments for high unmet medical need osteoarticular conditions (e.g. bone, joint, tendon/ligament) for small companion animals such as dogs. TheraVet’s mature product portfolio is composed of innovative synthetic, biological and cellular products developed from clinical stage and marketed human products.